Early research (Phase 1)Active Not RecruitingNCT06125197
What this trial is testing
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
Who this might be right for
Lung Cancer
TILT Biotherapeutics Ltd. 22